Textination Newsline

21.02.2023

Consortium for enzymatic textile recycling gains new supporters

"Shared vision of a true circular economy for the textile industry"

US fashion group PVH has joined the fibre-to-fibre consortium founded by Carbios, On, Patagonia, PUMA and Salomon. The aim is to support the further development of Carbios' biorecycling process on an industrial scale, setting new global standards for textile recycling technologies. PVH owns brands such as Calvin Klein and Tommy Hilfiger. In the agreement signed by PVH Corp, the company commits to accelerating the textile industry's transition to a circular economy through its participation in the consortium.

Carbios is working with On, Patagonia, PUMA, PVH Corp. and Salomon to test and improve its bio-recycling technology on their products. The aim is to demonstrate that this process closes the fibre-to-fibre loop on an industrial scale, in line with sustainability commitments.

"Shared vision of a true circular economy for the textile industry"

The two-year cooperation project will not only enable the biological recycling of polyester articles on an industrial scale, but also develop thorough sorting and disassembly technologies for complex textile waste. Existing members voted unanimously for PVH Corp. to join the consortium, saying the common goal is to support the development of viable solutions that address the fashion industry's contribution to climate change..

Carbios has developed a technology using highly selective enzymes that can recycle mixed feedstocks, reducing the laborious sorting required by current thermomechanical recycling processes. For textiles made from blended fibres, the patented enzyme acts only on the PET polyester contained within. This innovative process produces recycled PET (r-PET) that is equivalent in quality to virgin PET and can be used to produce new textile fibres.

Textile waste treatment and recycling
Globally, only 13% of textile waste is currently recycled, mainly for low-value applications such as upholstery, insulation or rags. The remaining 87% is destined for landfill or incineration. To work on improving textile recycling technologies, consortium members will supply feedstock in the form of clothing, underwear, footwear and sportswear. In 2023, a new PET textile waste facility will be commissioned at the Carbios demonstration plant, notably as part of the LIFE Cycle of PET project co-funded by the European Union. This is in anticipation of future regulations, such as the separate collection of textile waste, which will be mandatory in Europe from 1 January 2025.

From fibre to fibre: circularity of textiles
Today, the textile industry relies largely on non-renewable resources to produce fibres and fabrics, partly turning to recycled PET bottles for recycled polyester fibres. However, this resource will become scarce as PET bottles are used exclusively for the production of new bottles in the food and beverage industry. In a circular economy, the materials used to produce textiles are obtained from recycled or renewable raw materials produced by regenerative processes. In addition to supplying raw materials for the demonstration plant, the consortium members also aim to produce new products from r-PET fibres using the company's biorecycling process.

"Partnering with Carbios and its consortium members demonstrates our continued commitment to incorporating more circular materials into our collections," said Esther Verburg, EVP, Sustainable Business and Innovation, Tommy Hilfiger Global and PVH Europe. "We are excited to support the development of Carbios' enzymatic recycling technology and to leverage new solutions that can help us drive fashion sustainably."

More information:
Carbios textile recycling enzymatic

Source:

Carbios / Textination

Innovative wound care: Customized wound dressings made from tropoelastin

Customized, biomedically applicable materials based on tropoelastin are being developed in a joint project by Skinomics GmbH from Halle, Martin Luther University Halle-Wittenberg and the Fraunhofer Institute for Microstructure of Materials and Systems IMWS. The material combines biocompatibility, durability, biodegradability and favorable mechanical properties similar to those of skin. Preclinical tests have confirmed that it is suitable for use as a wound dressing material used in the treatment of chronic and complex wounds.

Particularly in the context of an aging society, special wound dressings are gaining in importance. The treatment of complex wound diseases such as venous ulcers, leg ulcers, or foot ulcers is challenging for medical staff, long-term and painful for those affected and cost-intensive for the healthcare system. Innovative protein-based materials are now being used for the treatment of such wounds. However, since they are made from animal tissues, they carry increased risks of infection or can result in undesirable immune reactions. In addition, there are increasing reservations in the population about medical products of animal origin.

In the joint research project, the project partners are currently developing customized, biomedically applicable materials based on human tropoelastin. This precursor protein is converted in the body to elastin, a vital and long-lived structural biopolymer that has exceptional mechanical properties and thus gives the skin and other organs the elasticity and resilience they need to function.

“Elastin is chemically and enzymatically extremely stable, biocompatible and does not produce immunological rejections when used as a biomaterial in humans. Therefore, we want to create new and innovative solutions for the treatment of complex wounds based on human tropoelastin,” says Dr. Christian Schmelzer, Head of the Department of Biological and Macromolecular Materials at Fraunhofer IMWS.

Individual wound treatment
As part of the research project led by Prof. Dr. Markus Pietzsch of Martin Luther University Halle-Wittenberg, the researchers succeeded in developing a biotechnological process for modifying tropoelastin. The modified tropoelastin is processed at Fraunhofer IMWS. Here, an electrospinning procedure is used to produce ultra-thin nanofibers with diameters of only a few hundred nanometers. The resulting nonwovens are further crosslinked to stabilize them for the respective application. The procedures developed have been optimized so that biomedical parameters such as pore size, stability and mechanical properties are variable and can thus be customized to meet the requirements of the respective wound treatment. The materials produced using the new procedures are being investigated by Skinomics GmbH in initial preclinical tests with regard to their skin compatibility and have already achieved promising results.

At the end of the project by the end of this year, applications for intellectual property rights are to be filed, building the basis for a subsequent product development phase for certified medical products.

Search

Sitemap

Consortium for enzymatic textile recycling gains new supporters

Innovative wound care: Customized wound dressings made from tropoelastin